Table 2.
Diagnoses for PH Patients.
| U. Heidelberg | U. Zürich | |
|---|---|---|
| (exercise intervention) | (oxygen intervention) | |
| Total number of PH patients | 31 (100%) | 21 (100%) |
| Primary diagnosis1 | ||
| Idiopathic PAH | 19 (61%) | 12 (57%) |
| Heritable PAH | 7 (22.6%) | |
| Associated PAH | ||
| connective tissue disease | 2 (6.5%) | 1 (4.8%) |
| portal hypertension | 2 (6.5%) | 1 (4.8%) |
| congenital heart disease | 1 (3.2%) | |
| Chronic thromboembolic PH | 7 (33%) | |
| Additional diagnosis2 | ||
| Number of patients who had additional diagnoses | 27 (87%) | 21 (100%) |
| Transient embolic episodes of the pulmonary artery | 6 (19%) | |
| Peripheral vascular disease (hypertension, subdural hematoma, arterial blockage, chronic venous disease) | 9 (29%) | 8 (38%) |
| Chronic lung disease (COPD, airway hyperreactivity, airway obstruction, asthma) | 8 (26%) | 6 (28%) |
| Left heart disease and/or heart rhythm abnormalities | 7 (23%) | 6 (28%) |
| Anemia, or iron therapy | 8 (26%) | 2 (9.5%) |
| Auto-immune disease (e.g., insulin dependent diabetes, or autoimmune thyroiditis) | 3 (9.7%) | 2 (9.5%) |
| Kidney disease | 5 (16%) | 5 (24%) |
| Tumor | 2 (6.5%) | 1 (4.8%) |
1One primary diagnosis per patient. All patients received PH specific medication.
2One or more additional diagnoses per patient. The patients received diagnosis specific medication as needed.